Azacitidine plus venetoclax in patients with high-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: phase 1 results of a single-centre, dose-escalation, dose-expansion, phase 1–2 study
Titel:
Azacitidine plus venetoclax in patients with high-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: phase 1 results of a single-centre, dose-escalation, dose-expansion, phase 1–2 study
Auteur:
Bazinet, Alexandre Darbaniyan, Faezeh Jabbour, Elias Montalban-Bravo, Guillermo Ohanian, Maro Chien, Kelly Kadia, Tapan Takahashi, Koichi Masarova, Lucia Short, Nicholas Alvarado, Yesid Yilmaz, Musa Ravandi, Farhad Andreeff, Michael Kanagal-Shamanna, Rashmi Ganan-Gomez, Irene Colla, Simona Qiao, Wei Huang, Xuelin McCue, Deborah Mirabella, Bailey Kantarjian, Hagop Garcia-Manero, Guillermo